Skip to main content

Dr. Nathan A. Summers, M.D.

Infectious Disease (Infectious Disease Physician)

  • Medicare participating

At a glance

Years since graduation
13
In the NPI registry since
2013
Medicare patients seen, 2024
113

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is

Education and training

  • 2013Medical school: University of Tennessee, Hsc, College of Medicine
  • 2013Registered with an NPI (national billing number; not a license date)

Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Infectious Disease Physician primary
    TN license 59040

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Infectious Disease per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
113
Services billed
257
Patients’ average age
66
Most frequent Medicare services, 2023
ServiceTimesPatients
Established patient office or other outpatient visit, 30-39 minutes13271
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes7024
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes2220

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Most prescribed drugs, Medicare Part D 2024
DrugPrescriptions
Biktarvy (bictegrav/emtricit/tenofov ala)312
Atorvastatin Calcium
Other prescribers in Memphis, TN
148
Amlodipine Besylate
Other prescribers in Memphis, TN
143
Genvoya (elviteg/cob/emtri/tenof alafen)126
Triumeq (abacavir/dolutegravir/lamivudi)119
Juluca (dolutegravir/rilpivirine)117
Tivicay (dolutegravir sodium)113
Albuterol Sulfate Hfa (albuterol sulfate)
Other prescribers in Memphis, TN
94
Losartan Potassium
Other prescribers in Memphis, TN
73
Gabapentin
Other prescribers in Memphis, TN
65

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Industry-funded research

Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $2,250 in research payments for these studies, mostly to the institutions running them.

  • A Phase 3, Double-Blind, Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous Twice Yearly Long-Acting Lenacapavir for HIV Pre-Exposure Prophylaxis in Cisgender Men, Transgender Women, Tra…
    Gilead Sciences, Inc.

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Infectious Disease clinicians in Memphis

Sources

NPI registry (CMS NPPES, November 2026; record last updated June 3, 2019), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1649512468. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.